Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome

European Journal of Endocrinology

Volumn 166, Issue 1, 2012, Pages 35-42

  Trementino, Laura ^a   Appolloni, Gloria ^a   Concettoni, Carolina ^a   Cardinaletti, Marina ^a   Boscaro, Marco ^a   Arnaldi, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE;

ADULT; ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DEVELOPMENTAL GENE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GR GENE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK REDUCTION;

ADULT; CUSHING SYNDROME; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID;

EID: 84055184761     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0722     Document Type: Article

References (38)

1. Etxabe J & Vazquez JA. Morbidity and mortality in Cushing's disease: an epidemiological approach. Clinical Endocrinology 1994 40 479-484. (doi:10.1111/j.1365-2265.1994.tb02486.x)
2. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K & Weeke J. Incidence and late prognosis of Cushing's syndrome: a population-based study. Journal of Clinical Endocrinology and Metabolism 2001 86 117-123. (doi:10.1210/jc. 86.1.117)
3. Orth DN. Cushing's syndrome. New England Journal of Medicine 1995 332 791-803. (doi:10.1056/NEJM199503233321207)
4. Boscaro M, Barzon L, Fallo F & Sonino N. Cushing's syndrome. Lancet 2001 357 783-791. (doi:10.1016/S0140-6736(00) 04172-6)
5. Bertagna X, Raux-Demay MC, Guilhaume B, Girard F & Luton JP. Cushing's disease. In The Pituitary, pp 592-612. Ed. S Melmed, Cambridge: Blackwell, 1995.
6. Newell-Price J, Trainer P, Besser GM & Grossman AB. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews 1998 19 647-672. (doi:10.1210/er.19.5.647)
7. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A & Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602. (doi:10.1210/jc.2003-030871)
8. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE, de Jong FH & Lamberts SW. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. Journal of Clinical Endocrinology and Metabolism 1998 83 47-54. (doi:10.1210/jc.83.1.47)
9. Zhou J & Cidlowski JA. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 2005 70 407-417. (doi:10.1016/j.steroids.2005.02.006)
10. Manenschijn L, van den Akker Erica LT, Lamberts Steven WJ & van Rossum Elisabeth FC. Clinical features associated with glucocorticoid receptor polymorphisms: an overview. Annals of the New York Academy of Sciences 2009 1179 179-198. (doi:10. 1111/j.1749-6632.2009.05013.x)
11. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH & Lamberts SW. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. Journal of Clinical Endocrinology and Metabolism 1998 83 144-151. (doi:10.1210/jc.83.1.144)
12. van Rossum EF, Koper JW, van den Beld AW, Uitterlinden AG, Arp P, Ester W, Janssen JA, Brinkmann AO, de Jong FH, Grobbee DE, Pols HA & Lamberts SW. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clinical Endocrinology 2003 59 585-592. (doi:10.1046/j.1365-2265.2003.01888.x)
13. van Rossum EF & Lamberts SW. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Progress in Hormone Research 2004 59 333-357. (doi:10.1210/rp.59.1.333)
14. van Schoor NM, Dennison E, Lips P, Uitterlinden AG & Cooper C. Serum fasting cortisol in relation to bone, and the role of genetic variations in the glucocorticoid receptor. Clinical Endocrinology 2007 67 871-878. (doi:10.1111/j.1365-2265.2007.02978.x)
15. Di Blasio AM, van Rossum EF, Maestrini S, Berselli ME, Tagliaferri M, Podestá F, Koper JW, Liuzzi A & Lamberts SW. The relation between two polymorphisms in the glucocorticoid receptor gene and body mass index, blood pressure and cholesterol in obese patients. Clinical Endocrinology 2003 59 68-74. (doi:10. 1046/j.1365-2265.2003.01798.x)
16. van Rossum EF, Koper JW, Huizenga NA, Uitterlinden AG, Janssen JA, Brinkmann AO, Grobbee DE, de Jong FH, van Duyn CM, Pols HA & Lamberts SW. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 2002 51 3128-3134. (doi:10.2337/diabetes.51.10.3128)
17. van Rossum EF, Voorhoeve PG, te Velde SJ, Koper JW, Delemarrevan de Waal HA, Kemper HC & Lamberts SW. The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. Journal of Clinical Endocrinology and Metabolism 2004 89 4004-4009. (doi:10.1210/jc.2003-031422)
18. van Rossum EF, Feelders RA, van den Beld AW, Uitterlinden AG, Janssen JA, Ester W, Brinkmann AO, Grobbee DE, de Jong FH, Pols HA, Koper JW & Lamberts SW. Association of the ER22/23EK polymorphismin the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men. American Journal of Medicine 2004 117 158-162. (doi:10.1016/j.amjmed.2004.01.027)
19. Oakley RH, Sar M & Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties and putative function. Journal of Biological Chemistry 1996 271 9550-9559. (doi:10.1074/jbc.271.16.9550)
20. Bamberger CM, Bamberger AM, de Castro M & Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. Journal of Clinical Investigation 1995 95 2435-2441. (doi:10.1172/JCI117943)
21. Oakley RH, Jewell CM, Yudt MR, Bofetiado DM & Cidlowski JA. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. Journal of Biological Chemistry 1999 274 27857-27866. (doi:10.1074/jbc. 274.39.27857)
22. Leung DY, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP & Klemm DJ. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. Journal of Experimental Medicine 1997 186 1567-1574. (doi:10.1084/jem.186.9.1567)
23. Schaaf MJ & Cidlowski JA. AUUUA motifs in the 3′ UTR of human glucocorticoid receptor alpha and beta mRNA destabilize mRNA and decrease receptor protein expression. Steroids 2002 67 627-636. (doi:10.1016/S0039- 128X(02)00015-6)
24. de Castro M, Elliot S, Kino T, Bamberger C, Karl M, Webster E & Chrousos GP. The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Molecular Medicine 1996 2 597-607. (Pubitemid 26353108)
25. van den Akker EL, Koper JW, van Rossum EF, Dekker MJ, Russcher H, de Jong FH, Uitterlinden AG, Hofman A, Pols HA, Witteman JC & Lamberts SW. Glucocorticoid receptor gene and risk of cardiovascular disease. Archives of Internal Medicine 2008 168 33-39. (doi:10.1001/archinternmed.2007.41)
26. Syed AA, Irving JA, Redfern CP, Hall AG, Unwin NC, White M, Bhopal RS & Weaver JU. Association of glucocorticoid receptor polymorphismA3669Gin exon9betawith reduced central adiposity in women. Obesity 2006 14 759-764. (doi:10.1038/oby.2006.86)
27. Szappanos A, Patócs A, Tõke J, Boyle B, Sereg M, Majnik J, Borgulya G, Varga I, Likó I, Rácz K & Tóth M. BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clinical Endocrinology 2009 71 636-643. (doi:10.1111/j.1365-2265.2009.03528.x)
28. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 152-640. (doi:10.1210/jc.2008-0125)
29. Laragh JH & Brenner BM. In Hypertension: Pathophysiology, Diagnosis and Management, 2nd edn, pp 1987. Raven Press: New York, 1995.
30. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497. (doi:10. 1001/jama.285.19.2486)
31. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003 26 S5-S20. (doi:10.2337/diacare.26.2007. S5)
32. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10. 1007/BF00280883)
33. Santos-Montes A, Gonzalo-Lumbreras R & Izquierdo-Hornillos R. Simultaneous determination of cortisol and cortisone in urine by reversed-phase high-performance liquid chromatography. Clinic and doping control application. Journal of Chromatography 1995 673 27-33. (doi:10.1016/0378-4347(95)00253-F)
34. Tremblay A, Bouchard L, Bouchard C, Després JP, Drapeau V & Pérusse L. Long-term adiposity changes are related to a glucocorticoid receptor polymorphism in young females. Journal of Clinical Endocrinology and Metabolism 2003 88 3141-3145. (doi:10.1210/jc.2002-021521)
35. Ukkola O, Pérusse L, Chagnon YC, Després JP & Bouchard C. Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in Québec Family Study. International Journal of Obesity and Related Metabolic Disorders 2001 25 1332-1339. (doi:10.1038/sj.ijo.0801735)
36. Morelli V, Donadio F, Eller-Vainicher C, Cirello V, Olgiati L, Savoca C, Cairoli E, Salcuni AS, Beck-Peccoz P & Chiodini I. Role of glucocorticoid receptor polymorphism in adrenal incidentalomas. European Journal of Clinical Investigation 2010 40 803-811. (doi:10.1111/j.1365-2362.2010.02330.x)
37. Pivonello R, De Leo M, Vitale P, Cozzolino A, Simeoli C, De Martino MC, Lombardi G & Colao A. Pathophysiology of diabetes mellitus in Cushing's Syndrome. Neuroendocrinology 2010 92 (Suppl 1) 77-81. (doi:10.1159/000314319)
38. Mancini T, Kola B, Mantero F, Boscaro M & Arnaldi G. High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clinical Endocrinology 2004 61 768-777. (doi:10.1111/j.1365- 2265.2004.02168.x)